CD44 Isoform Status Predicts Response to Treatment with Anti-CD44 Antibody in Cancer Patients

201555 citationsJournal Article

Authors

We provide new insights into the close interplay between CD44 and HA and a potential biomarker to enrich patient responses to RG7356 in the clinic.

Good health and well-being

Published in: Clinical Cancer Research

Volume 21, Issue 12, pp. 2753-2762

Field-Weighted Citation Impact: 3.14